Everest Organics Limited (BOM:524790)
229.00
-10.55 (-4.40%)
At close: Sep 25, 2026
Everest Organics Revenue
Everest Organics had revenue of 488.50M INR in the quarter ending June 30, 2026, a decrease of -10.14%. This brings the company's revenue in the last twelve months to 1.92B, up 5.58% year-over-year. In the fiscal year ending March 31, 2026, Everest Organics had annual revenue of 1.97B with 22.98% growth.
Revenue (ttm)
1.92B
Revenue Growth
+5.58%
P/S Ratio
1.16
Revenue / Employee
6.07M
Employees
316
Market Cap
2.22B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.97B | 367.58M | 22.98% |
| Mar 31, 2025 | 1.60B | -380.82M | -19.23% |
| Mar 31, 2024 | 1.98B | 141.55M | 7.70% |
| Mar 31, 2023 | 1.84B | -177.25M | -8.79% |
| Mar 31, 2022 | 2.02B | 195.19M | 10.72% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.73B |
| Medico Remedies | 2.38B |
| Sat Kartar Life | 2.01B |
| Gennex Laboratories | 1.78B |
| Kerala Ayurveda | 1.36B |
| Oxygenta Pharmaceutical | 1.35B |
| BDH Industries | 997.10M |
| Coral Laboratories | 967.01M |